A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients
Clinical trial NCT07690319 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07690319
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-10-15
- Primary completion
- 2027-03-15
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.